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All Hedgehog (Hh) proteins are released from
producing cells despite being synthesized as N-
and C-terminally lipidated, membrane-tethered
molecules. Thus, a cellular mechanism is needed
for Hh solubilization. We previously suggested that
a disintegrin and metalloprotease (ADAM)-mediated
shedding of Sonic hedgehog (ShhNp) from its lipi-
datedN andC termini results in protein solubilization.
This finding, however, seemed at odds with the es-
tablished role of N-terminal palmitoylation for ShhNp
signaling activity. We now resolve this paradox by
showing that N-palmitoylation of ShhNp N-terminal
peptides is required for their proteolytic removal
during solubilization. These peptides otherwise
block ShhNp zinc coordination sites required for
ShhNp binding to its receptor Patched (Ptc), explain-
ing the essential yet indirect role of N-palmitoylation
for ShhNp function.We suggest a functional model in
which membrane-tethered multimeric ShhNp is at
least partially autoinhibited in trans but is processed
into fully active, soluble multimers upon palmitoyla-
tion-dependent cleavage of inhibitory N-terminal
peptides.
INTRODUCTION
Vertebrates produce three structurally and functionally related
Hedgehog (Hh) morphogens (Sonic Hh, Indian Hh, and Desert
Hh). Production of active Sonic hedgehog (ShhNp) protein
begins with autocatalytic cleavage of a 45 kDa precursor mole-
cule, resulting in a 19 kDa, C-terminally cholesterol-linked
signaling domain (amino acids 25–198 of murine Shh, amino
acids 24–197 of human Shh). Next, acyltransferases (Skinny
hedgehog [Ski] in the fly, Skn/Hhat in vertebrates) attach a palmi-
toyl group to the N terminus of this domain. Hh palmitoylation is
special in that the palmitate is attached via an amide bond to the
a-amino group of the N-terminal cysteine, in contrast to
S-acylation targeting the thiol side chain in nearly all other palmi-764 Developmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Itoylated proteins (Buglino andResh, 2008; Pepinsky et al., 1998).
Shh palmitoylation during synthesis is critical for later signaling.
Mutation of the N-terminal cysteine to serine results in mutant
forms (ShhNpC24S in human Shh and ShhNpC25S in the mouse,
HhNpC85S in fly Hh) that do not undergo palmitoylation (Pepinsky
et al., 1998) and that show reduced patterning activity in the
mouse limb and neural tube, comparable to the respective
acyltransferase-deficient mutants (Chamoun et al., 2001; Chen
et al., 2004; Dawber et al., 2005; Goetz et al., 2006; Kohtz
et al., 2001; Lee et al., 2001).
On the surface of producing cells, dual Hh lipidation results in
the formation of nanoscale oligomers that colocalize with hep-
aran sulfate (HS) proteoglycans (HSPGs) (Vyas et al., 2008). HS
binds to the Cardin-Weintraub (CW) motif found on all known
Hhs and regulates their function in flies (Bellaiche et al., 1998;
Desbordes and Sanson, 2003) and mice (Grobe et al., 2005). In
Drosophila (Pana´kova´ et al., 2005) and in mammalian cell culture
(Zeng et al., 2001), lipidated Hhs (but not the unlipidated, artificial
forms called HhN/ShhN) are then released in multimeric form
that strongly initiate the Hh response in cells expressing the Hh
receptor Patched (Ptc). Release of the lipidated protein from
the cell surface depends on the expression of Dispatched
(Disp), a 12 transmembrane domain/sterol-sensing domain
protein (Burke et al., 1999; Caspary et al., 2002; Kawakami
et al., 2002; Ma et al., 2002) and a disintegrin and metallopro-
tease (ADAM)17 that mediates ectodomain shedding from trans-
fected Bosc23 cells, a HEK293T-derived cell line (Dierker et al.,
2009b).
However, several important questions remain unanswered:
Why is the sequence of lipid modification, firm attachment to
the cell surface, multimerization, and multimer release via shed-
ding essential for effective secretion and function of ShhNp? Are
these steps functionally interdependent? Why is the protein
dually lipidated during synthesis? Specifically, the postulated
shedding mechanism seemed incompatible with the essential
role of N-palmitoylation during synthesis for ShhNp biological
activity. In this work, we show that ShhNp zinc coordination sites
are occupied in trans byN-terminal peptides of adjacent proteins
in the cluster, effectively blocking the ability of these sites to bind
to their receptor Ptc and rendering the protein inactive.
Membrane-proximal proteolytic cleavage of N-terminal peptides
during solubilization depends on ShhNp N-palmitoylation and is
the prerequisite for subsequent Ptc binding and biologicalnc.
Figure 1. ADAM-Mediated Posttranslational Shh Processing
Results in the Loss of N-Terminal Palmitoylation
(A) Immunoblot analysis of released ShhNp following cotransfection of Bosc23
cells with full-length Shh cDNA and plasmids encoding for ADAM10, ADAM12,
and ADAM17, or an empty plasmid (mock). Graphs express the ratio of shed
versus cell-bound ShhNp after immunoblotting and quantification relative to
the ratio obtained with themock control, which was set to 100% (n = 4). ShhNp
release was increased about 2-fold following ADAM cotransfection (ADAM10:
194% ± 15%, p% 0.0018 [**p < 0.01)]; ADAM12: 204% ± 20%, p% 0.0055;
ADAM17: 236% ± 16%, p% 0.0002 [***p < 0.001]). Error estimates are stan-
dard deviations of the mean.
(B) Left: ShhNp secreted into the medium was analyzed together with the cell
lysate by immunoblotting after reducing 15% SDS-PAGE. Increased electro-
phoretic mobility of the soluble protein (m, medium; arrow) compared to cell-
tethered ShhNp (c, cell; arrowhead) indicates proteolytic processing. Right:
immunoblot (top) and autoradiograph (bottom) of [9,10(n)-3H] palmitic acid-
labeled, full-length ShhNp in the cell lysate (c) and the medium (m). Full-length
19 kDa ShhNp (arrowhead) was detected in lysates and medium by western
blotting and autoradiography. In contrast, truncated soluble ShhNp (arrow)
was not 3H-palmitic acid labeled, demonstrating N-terminal processing.
Unprocessed soluble ShhNp is explained by extensive cell death due to the
serum-free conditions required for labeling.
(C) ShhNp-transfected Bosc23 cells released ‘‘large’’ (>600 kDa) and ‘‘small’’
(70–600 kDa) multimers (Feng et al., 2004). Unlipidated ShhN was monomeric
(n = 3). Molecular weight standards and corresponding fractions are indicated.
(D) Shh biological activity does not correspond with Shh multimerization or
lipidation. C3H10T1/2 osteoblast precursor cells were incubated with ShhNp,
sAP-ShhN, E. coli-expressed ShhN, or control media, and Hh-dependent cell
differentiation was determined. ShhNp, sAP-ShhN, and ShhN all strongly
induced C3H10T1/2 differentiation; in contrast, ShhNpC25S was only moder-
ately active. C3H10T1/2 differentiation was blocked by CA, a specific inhibitor
of Shh signaling (2.5 mg/ml; p % 0.001; n = 3). Bottom: Shh constructs em-
ployed in this study. P, N-terminal palmitate; C, C-terminal cholesterol.
Numbers denote respective amino acid residues; asterisks indicate the loca-
tion of S25. Error estimates are standard deviations of the mean. Physiologi-
cally relevant production of ShhNp in Bosc23 cells is supported by data pre-
sented in Figure S1.
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Develactivity of the ShhNp cluster. These findings reveal an unex-
pected functional link between ShhNp lipidation, multimeriza-
tion, and sheddase-mediated release of a truncated protein
and provide an explanation for the essential role of N-palmitoy-
lation for ShhNp biological activity.
RESULTS
Processing and Secretion of ShhNp
Among the most unusual features of Shh proteins is their uncon-
ventional posttranslational processing (Bijlsma et al., 2004)
resulting in dually lipidated, cell-tethered multimeric ShhNp.
Disp-dependent ShhNp secretion from transfected Bosc23 cells
is completed by ADAM17-mediated shedding, resulting in the
solubilization of biologically active ShhNp lacking both lipidated
termini (see Figure S1 available online) (Dierker et al., 2009b).
Because redundancy in enzymes and substrates is common
among ADAM family members (Kheradmand and Werb, 2002;
Vu and Werb, 2000), we tested ShhNp release upon cotransfec-
tion with ADAM10, ADAM12, and ADAM17. In all three cases,
ShhNp solubilization was increased 2-fold if compared to
a mock/ShhNp-transfected control (Figure 1A), demonstrating
that multiple sheddases can contribute to ShhNp solubilization.
ShhNp truncation upon shedding was consistent with increased
electrophoretic mobility of the soluble protein upon SDS-PAGE
when compared to the cell-bound form (Figure 1B, left).
To directly test for the loss of N-terminal, membrane-associ-
ated (Feng et al., 2004) palmitate during shedding, ShhNp-over-
expressing cells were grown in the presence of [9,10(n)-3H]
palmitic acid. Released ShhNp was subjected to heparin-
agarose pull-down, separated by SDS-PAGE, and analyzed by
immunoblotting and autoradiography together with the cell
lysate. As shown in Figure 1B, a-ShhN antibodies detected
19 kDa Shh proteins in the cell lysate (c), and released processed
and unprocessed ShhNp in the medium (m). In contrast, [3H]
palmitate labeled only unprocessed ShhNp associated with the
cells or released into the medium, but not the truncated protein
(arrow), indicating loss of the lipid moiety during processing.
From these findings, we concluded that ShhNp palmitoylation
likely fulfills its essential biological role prior to or in conjunction
with ADAM-mediated shedding.
This conclusion was backed by two additional observations.
First, gel filtration chromatography revealed that soluble (trun-
cated) ShhNp remained multimeric (fractions 1–9, correspond-
ing to >600–70 kDa, Figure 1C). In contrast, unlipidated,
E. coli-expressed ShhN was exclusively monomeric (fraction
11, corresponding to a molecular weight of 20 kDa). This
suggests that N-terminal palmitic acid is not required for multi-
mer stabilization in solution. Second, N-palmitoylation per se is
also not required for Shh biological activity, as shown by Hh-
dependent differentiation of C3H10T1/2 osteoblast precursor
cells (Nakamura et al., 1997) (Figure 1D). As a control, media
obtained from untransfected Bosc23 cells did not induce differ-
entiation (mock); in contrast, multimeric ShhNp conditioned
media were active. The teratogen cyclopamine (CA) (Cooper
et al., 1998) completely blocked the biological activity of
ShhNp-conditioned media (p % 0.001; n = 3), supporting that
C3H10T1/2 differentiation was due to ShhNp. Notably, E. coli-
expressed monomeric ShhN (Figure 1C) also inducedopmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Inc. 765
Figure 2. ShhNp Palmitoylation Is Required for N-Terminal Process-
ing during Release
(A) Top: immunoblot analysis of cell-tethered ShhNp and palmitoylation-defi-
cient ShhNpC25S. Both cell-bound HA-tagged 22 kDa proteins were detected
by a-ShhCW antibodies and a-HA antibodies. Bottom: immunoblot analysis of
MbCD-released proteins. In contrast to the soluble 21.4 kDa mutant protein,
a-HA reactivity of the soluble wild-type cluster was abolished. Concomitantly,
a 19.6 kDa truncated form of the wild-type protein was detected by a-ShhCW
antibodies on the same (stripped) blot.
(B) Gel filtration chromatography showing that ShhNp multimerization was
mildly affected upon HA insertion. HA-tagged ShhNp or ShhNpC25S formed
relatively reduced amounts of ‘‘large’’ (>600 kDa) multimers and increased
relative levels of ‘‘smaller’’ (100 kDa) multimers if compared to untagged
ShhNp, and monomeric proteins were also observed (fraction 11, 20 kDa).
Elution profiles are expressed relative to the highest amount of each protein
detected in a given fraction, which was set to 100%.
(C) Site-directed mutagenesis of the HS-binding CW motif results in consti-
tutive release of truncated proteins (bottom band). In contrast, soluble
ShhNpC25S is N-terminally untruncated, consistent with only C-terminal pro-
cessing required during release. c, cell lysate; m, medium.
(D) RNAi-mediated Hhat knockdown impairs ShhNp5xA processing. Increased
amounts of Hhat-esiRNA result in correspondingly impaired ShhNp5xA pro-
cessing (bottom band), and increased release of unprocessed ShhNp5xA (top
band). esiRNA1 (targeting GFP) served as a control. (E) Constitutive ShhNp5xA
truncation upon release is attenuated in a compound mutant form lacking
N-terminal palmitoylation (ShhNpC25S;5xA). Bottom: Shh constructs employed.
See also Figure S2.
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ing of ShhN and human secreted alkaline phosphatase (sAP) as
a nonpalmitoylated, N-terminal tag.
These findings suggested a dispensable role of N-terminal pal-
mitoylation for biological activity of the ShhN monomer, whereas
palmitoylation-deficient multimeric ShhNpC25S (Buglino and
Resh, 2008; Pepinsky et al., 1998) had decreased activity (Fig-
ure 1D). Therefore, we hypothesized that N-palmitoylation may766 Developmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Ibe specifically required for biological activity of the multimeric
protein.An important biochemical differencebetweenmultimeric,
lipidated ShhNp and monomeric ShhN is that only the former
undergoes ADAM-mediated dual processing during release.
Because ADAM-mediated processing of substrates generally
occurs within a 1–20 residue stalk segment adjacent to the
plasma membrane, we further hypothesized that N-terminal pal-
mitoylation may be required for membrane-proximal positioning
of the sheddase cleavage site; in this case, deletion of the palmi-
tatemay result in aberrant positioning and impaired processing of
the N terminus, followed by the release of an N-terminally unpro-
cessed (but C-terminally processed) protein from Bosc23 cells.
To test this idea, and to monitor N-terminal protein processing
upon release, we employed peptide-tagged forms of ShhNp and
the N-terminal cysteine to serine mutant ShhNpC25S. In vivo
studies have shown that mouse embryos expressing ShhNpC25S
exhibit similar defects to those in ski (skn/hhat)-deficient
embryos due to defective short- and long-range Shh signaling
(Chen et al., 2004), and fly ski mutants also showed comparable
phenotypes to mutants expressing HhNpC85S instead of wild-
type HhNp protein (Chamoun et al., 2001). This demonstrates
that a cysteine to serine change at the N-terminal position abol-
ishes ShhNp palmitoylation. Sequence analysis of N-terminal Hh
peptides (Dierker et al., 2009a) revealed a block of conserved
residues required for N-terminal acylation (residues 25–30 in
mouse Shh) followed by the HS-binding CW sequence defined
by amino acids 33–39 (Buglino and Resh, 2008; Rubin et al.,
2002). By site-directed mutagenesis, we inserted an internal
hemagglutinin (HA) tag between residues G32 and K33 of ShhNp
and ShhNpC25S, resulting in the N-terminal peptide sequence C/
S25GPGRGFG32-YPYDVPDYA-K33RRHPKK39 (underlined itali-
cized letters represent the tag), and expressed the proteins in
Bosc23 cells (Figure 2A). Gel filtration analysis was conducted
to test whether the HA tag impaired the ability of the proteins
to multimerize (Figure 2B). Compared to untagged wild-type
ShhNp, both tagged forms tended to form fewer large multimer
clusters exceeding a molecular weight of 600 kDa (fractions 1–4),
whereas smaller clusters ranging in molecular weight from 250
to 70 kDa (fractions 7–9) were abundant. Notably, monomeric
protein was detected as well (fraction 11). The HA tag thus inter-
fered with, but did not abolish, ShhNp multimerization.
As shown in Figure 2A, HA-tagged ShhNp and ShhNpC25S
were detected as 22 kDa proteins on western blots of cell lysates
using antibodies directed against the HA tag and rabbit a-Shh
antibodies (a-ShhCW, binding the CW sequence). Cell surface
shedding of both proteins was then induced by methyl-b-cyclo-
dextrin (MbCD) treatment. Addition of MbCD results in the
extraction of cholesterol from living cells, thereby disrupting lipid
rafts and inducing ADAM-mediated ectodomain shedding (Dier-
ker et al., 2009b; Matthews et al., 2003). This treatment released
21.4 kDa ShhNpC25S detected by a-HA and a-ShhCW anti-
bodies, suggesting only C-terminal processing during release
(Figure 2A, bottom). In contrast, the wild-type protein was trun-
cated to 19.6 kDa and lacked a-HA-reactivity, indicating
N-terminal processing. Molecular weight analysis using BIO1D
software revealed the loss of a 1865 Da peptide, corresponding
to residues CGPGRGFG-YPYDVPDYA. This is consistent with
preserved a-ShhCW reactivity of the truncated protein (see
also Figure S2).nc.
Figure 3. The N Terminus of One ShhN Molecule Interacts with the Zinc Coordination Site of an Adjacent Molecule in the Cluster
Intermolecular interactions observed in the human ShhN crystal structure (PDB: 3M1N) (Pepinsky et al., 2000).
(A) Electrostatic interactions contribute to dimer formation (dimers within one unit cell are colored identically). Analysis of crystal symmetrymates further revealed
that N-terminal peptides (amino-terminal amino acids 25–45) wrap around symmetry-related molecules (c with b, c0 with d0). Asterisks indicate N termini.
(B and C) Surface representation of molecules b and d0 (as shown in A) interacting with the adjacent dimer (c, c0, colored in blue), showing N-terminal interaction
with the zinc coordination site. Zinc ions are shown as green spheres, and the location of zinc-coordinating residues H140, D148, and H182 is shown in red.
Yellow surface in (B) marks residues A44-Y45-K46 constituting the electrostatic contact site with the partner molecule of the dimer (b0 as shown in A). N termini
superimpose the zinc coordination sites of adjacent molecules differently: one N-terminal sequence interacts with only one adjacent molecule (c0 with d0 in A,
highlighted in C), the other locates at the interface between adjacent dimer subunits (c with b and b0 in A, highlighted in B). This results in a slightly different
orientation of the N termini.
(D) Gel filtration analysis of Bosc23-released ShhNp andmutant ShhNpC25S.Multimerization of ShhNpC25Swas not compromised, demonstrating that palmitate is
not required for ShhNp multimerization.
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ined the release of ShhNp from untreated cells. We previously
found that HS modulates ShhNp shedding (Dierker et al.,
2009b), and consistent with this, mutant ShhNp lacking a func-
tional HS-binding CW motif (ShhNp5xA) was constitutively shed
in truncated form from untreated cells (Figure 2C, c, cell; m,
medium). In contrast, soluble ShhNpC25S was detected in
N-terminally unprocessed form. This allowed us to test the role
of N-terminal palmitoylation for N-terminal processing by
RNAi-mediated knockdown of the acyltransferase Hhat (Fig-
ure S2) in ShhNp5xA-expressing cells. As shown in Figure 2D,
reduced Hhat activity correlated with increased relative amounts
of soluble unprocessed ShhNp5xA (top band), suggesting that N-
palmitoylation is required for N-terminal processing (bottom
band). We confirmed this finding by generating mutant proteins
lacking both the CW motif and the palmitate-acceptor C25
(ShhNpC25S;5xA). In contrast to ShhNp5xA, nonpalmitoylated
ShhNpC25S;5xA was released in unprocessed form (Figure 2E).
Thus, palmitoylation was required for N-terminal ShhNp pro-
cessing, and its loss resulted in the release of unprocessed
protein. These findings are consistent with the observation that
N-terminal proteolytic processing is implicated in the release ofDevelSpitz (Spi), a ligand for the Drosophila epidermal growth factor
receptor (EGFR) (Miura et al., 2006). In cultured cells, the acyl-
transferase Ski promotes N-palmitoylation of the N-terminal
cysteine residue of Spi, reducing its secretion and enhancing
its plasma membrane association. Notably, the sequence of
wild-type soluble (s)Spi released into the media of expressing
S2 cells begins at methionine 45, whereas a soluble, palmitoyla-
tion-deficient mutant sSpiC29S begins with the serine at position
29, immediately after the signal peptide. Moreover, the mamma-
lian homolog of Spi, TGFa, is released by ADAM17-mediated
processing (Peschon et al., 1998).
Specific, Function-Blocking ShhN Interactions
as Revealed by Crystal Symmetry
How does the N-terminal peptide affect Shh activity? Interest-
ingly, when the three-dimensional structure of human ShhN
(PDB: 3M1N) was solved, the amino terminus was found to
extend 30A˚ away from the globular domain of the protein (Goetz
et al., 2002; Pepinsky et al., 2000). In the crystal lattice structure
(Figure 3A), the amino-terminal extensions of one ShhN dimer
substructure (Shh monomers c and c0, shown in blue) interact
with hydrophobic pockets on two adjacent Shh moleculesopmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Inc. 767
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different arrangements (Figures 3B and 3C). In one arrangement,
the N terminus extends into the cleft formed by the two subunits
of the adjacent dimer, thereby contacting both subunits (b and
b0 in Figure 3A; the protein-protein contact site of the dimer is
shown in yellow in Figure 3B); in the other interaction, the
N terminus contacts only a single adjacent molecule (Figure 3A,
d0, and Figure 3C). In both cases, the N-terminal extensions
superimpose the zinc coordination sites of neighboring mole-
cules (zinc shown in green, coordinating residues in red in
Figures 3B and 3C) (Hall et al., 1995). However, in contrast to
Hedgehog-interacting protein (Hhip) loop 2 that also occupies
the Shh zinc coordination site (Bishop et al., 2009; Bosanac
et al., 2009), the N-terminal peptide does not make close polar
contact with the adjacent molecule and does not coordinate
the Zn2+ cation. Still, it was found that mutagenesis or deletion
of the N terminus impaired ShhNp multimerization (Goetz et al.,
2006). This finding is consistent with impaired multimerization
of HA-tagged ShhNp and ShhNpC25S (Figure 2B). Untagged
ShhNpC25S is exclusively multimeric in solution, consistent with
the findings of others (Figure 3D) (Feng et al., 2004).
Analysis of protein-protein contacts within one unit cell of the
3M1N structure suggested a second contact site involving resi-
dues E72, R73, and K75 with A44, Y45, and K46 of the partner
molecule (Figure 4A). This site had already been predicted as
a Shh contact site (Vyas et al., 2008). The requirement of this
second contact side for ShhNp multimerization was confirmed
by gel filtration of ShhNpR73E and ShhNpTri (E72A; R73A; K75A).
When compared to ShhNp, multimerization of mutant forms
was strongly impaired, resulting in smaller-sized multimers
(data not shown), often in addition to monomers (Figure 4B). As
shown in Figure 4C, ShhN, ShhNp, ShhNpR73E, and ShhNpTri all
showed comparable biological activities (p % 0.001 compared
to the mock-transfected control in all cases; n = 3), suggesting
that impaired multimerization of mutant proteins was not due to
misfolding that would have led to their inactivation. Full inhibition
of ShhNpTri biological activity by the inhibitory, conformation-
dependent 5E1 antibody supports this conclusion.
To test whether crystal lattice contacts represent another
potentially relevant interaction contributing to ShhNp multimeri-
zation, we analyzed the surface area buried by 3M1N protein-
protein interfaces using MSMS (Sanner et al., 1996). The
minimum size of a physiological protein-protein interface of
500 A˚2 (Chothia and Janin, 1975) was exceeded by two Shh
contact sites (Figures 4D–4F). One contact site buries 1003 A˚2
(blue molecule) and 898 A˚2 (green molecule), and the opposite,
symmetry-related contact site buries 902 A˚2 (blue molecule)
and 999 A˚2 (orange molecule). Note that repeated application
of the same symmetry operation would generate zigzag chains
of Shh molecules with each pair of neighboring molecules
sharing an interface of about 1000 A˚2; this suggests a possible
mode ofmultimerization. Formation of these interfaceswas likely
aided by the unique 3M1N N-terminal extension, in agreement
with its role in ShhNp multimerization (Goetz et al., 2006),
because a recent analysis of 14 independent Hh-containing
crystal lattices, all lacking N-terminal peptides, failed to reveal
any contact areas exceeding 500 A˚2 (Kavran et al., 2010).
Residues T41, N51, and E168 (mouse nomenclature) and K88,
E90, R124, D153, R154, and R156 located at both symmetry-768 Developmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Irelated interfaces. Interestingly, basic amino acids R124, R154,
and R156 made polar contacts with negatively charged sulfate
residues, suggesting that HSPGs may contribute to ShhNp mul-
timerization (Vyas et al., 2008). To test this idea, we expressed
biologically active ShhNp in CHO-K1 cells and a mutant cell
line deficient in HS production (pgs-D677). When compared to
CHO-K1-expressed ShhNp (Figure 4G), pgs-D677 ShhNp multi-
merization was strongly impaired, resulting in the release of
smaller-sized multimers in addition to monomeric ShhNp. This
supports the idea that HS assists the formation of ShhNp multi-
mers, or stabilizes these multimers. Size exclusion chromatog-
raphy of ShhNpPenta (K88A, E90A, R124D, D153A, R154A) also
revealed partially impaired multimerization of mutant proteins
(Figure 4H). Together, we conclude that the highly conserved
amino-terminal domain (Goetz et al., 2006), residues E72, R73
(Vyas et al., 2008), and K75, as well as residues K88, E90,
R124, D153, and R154 together with cell surface-expressed
HS may all contribute to ShhNp multimerization (see also
Figure S3).
Importantly, the findings described above indicate that the
arrangement of ShhN aggregates in the 3M1N crystal lattice
reflects, to substantial extent, the arrangement of ShhNp on ex-
pressing cells in vitro. The detection of multimeric ShhNpC25S in
solution (Figure 3D) thus suggests that the palmitoylation-defi-
cient protein may be released with the zinc coordination site still
occupied by the unprocessed N-terminal extension of another
molecule in the cluster.
The ShhNp N Terminus Blocks 5E1 Binding
to the Adjacent Molecule in the Cluster
In two recent reports, the Shh/Dhh zinc coordination site has
been identified as the binding site for the receptor Ptc as well
as the surface receptor antagonist, Hhip (Bishop et al., 2009;
Bosanac et al., 2009). As shown in Figure 5A, in crystal symmetry
mates the N-terminal peptide superimposes the Ptc binding site
(shown in red, residues H133, H134, H140, H180, andH182) (Bo-
sanac et al., 2009)without directly contacting this site (Figure S4).
This observation explains potentially the lack of biological
activity of ShhNpC25S in various systems (Chen et al., 2004;
Dawber et al., 2005; Goetz et al., 2006; Kohtz et al., 2001; Lee
et al., 2001) and in cell-based bioassays (Figure 1D). To test
this idea, we employed the conformation-dependent, mono-
clonal antibody 5E1 that was recently shown to specifically
bind to the Shh zinc coordination site (Maun et al., 2010) (Fig-
ure 5B). ShhNp, ShhNpC25S, and hexahistidine-tagged, mono-
meric 28 kDa ShhN6xh were expressed and proteins in the
medium pulled down using heparin Sepharose that strongly
binds all three forms, or immunoprecipitated using ProteinA-
coupled 5E1. We found comparable amounts of 5E1-immuno-
precipitated ShhN6xh and ShhNp compared to the amount of
material that bound to heparin, indicating efficient 5E1 binding.
In contrast, the relative amount of 5E1-immunoprecipitated
ShhNpC25S was strongly reduced (Figure 5C, asterisks), indi-
cating blockade of the 5E1 epitope.
To confirm 5E1 binding to N-terminally truncated protein clus-
ters, we next compared 5E1 binding to unprocessed ShhNpC25S
and the constitutively processed form, ShhNp5xA (Figures 2C–
2E). As shown in Figure 5D, ShhNp5xA was 5E1 immunoprecipi-
tated, in contrast to ShhNpC25S. 5E1 immunoprecipitation ofnc.
Figure 4. Intermolecular Interactions Observed in the Human ShhN Crystal Structure Reflect Similar Interactions in Multimeric ShhNp
(A) Intermolecular electrostatic interactions in the human ShhN crystal structure 3M1N involve residues E72 (blue), R73 (orange), and K75 (cyan). Additional
contacts via the extended N-terminal peptide of the symmetry-related molecule are observed (asterisk). Dimers are colored red; the N terminus of the interacting
molecule is green.
(B) Gel filtration analysis of Bosc23-released ShhNp and mutant forms ShhNpR73E and ShhNpTri (E72A, R73A, and K75A). ShhNpR73E multimerization was
impaired and ShhNpTri multimerization more strongly affected, resulting in an elution profile comparable to that of monomeric ShhN. ShhNpR73E and ShhNpTri
multimerization was variable, suggesting other contributing factors.
(C) ShhNp contactmutants are biologically active. ShhN, ShhNp, ShhNpR73E, and ShhNpTri all showed comparable biological activity in C3H10T1/2 differentiation
(p% 0.001 compared to the mock transfected control; n = 3), indicating that the overall structure of mutated proteins was unchanged. Medium obtained from
mock-transfected Bosc23 cells was used as a control. ShhNpTri-induced AP activity in C3H10T1/2 cells was entirely blocked by the teratogen CA (2.5 mg/ml) and
the neutralizing anti-Shh antibody 5E1 (1 mg/ml). Error estimates are standard deviations of the mean.
(D) Ribbon diagrams showing ShhN-ShhN crystal lattice interactions; residues located at the interfaces are displayed as sticks. Zinc cations and sulfates are
represented as spheres with asterisks and spheres, respectively. Areas of buried surface are indicated (arrows), and the respective buried surface areas were
quantified (Sanner et al., 1996).
(E and F) Close-up views of the binding interfaces. All residues at interfaces are absolutely conserved in all ShhN proteins from mouse, human, and chick, and
residues K88, E90, R124, D152, R153, R(K)156, and E168 (murine Shh) are absolutely conserved in vertebrate Ihh, Dhh, and Shh. Two sulfates are present at each
protein-protein interface, suggesting that HS may contribute to protein multimerization.
(G) Gel filtration analysis of ShhNp released from CHO-K1 cells and HS-deficient pgs-D677 cells. Multimerization of ShhNp expressed in pgs-D677 cells was
variably impaired if compared to CHO-K1-expressed ShhNp. However, pgs-D677-expressed ShhNp still formedmultimers, possibly due to the presence of FCS
(and the HS contained therein).
(H) Gel filtration analysis of Bosc23-released ShhNp and mutant ShhNpPenta (K88A, E90A, R124D, D153A, R154A). ShhNpPenta multimerization was affected to
varying degrees. Thus, three independent ShhNpPenta gel filtration profiles were pooled, and the averaged values are shown. See also Figure S3.
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N-terminal peptide 25CGPGRGFGK33 (data not shown). This
suggests the absence of direct contacts between this peptide
and the zinc coordination site, consistent with the lack of such
contacts in the crystal lattice structure (Figure S4).
N-terminal protein processing and truncation during release
was further confirmed by strong 5E1 binding of soluble ShhNp
multimers if compared to cell-tethered forms (Figure 5E). Again,
5E1 immunoprecipitation of ShhNpC25S failed to produce signalsDevelfor both the cell-tethered and soluble mutant proteins. Based on
these results, we hypothesized that Ptc binding of ShhNpC25S
might also be blocked. To test this idea, we analyzed
C3H10T1/2 osteoblast precursor cell differentiation induced by
ShhNp, ShhNpC25S, or a mixture of both. We expected
unchanged ShhNp activity in the presence of Ptc-incompetent
ShhNpC25S. In contrast, a dominant-negative effect on ShhNp
biological activity would be expected in case of ShhNpC25S
binding to, and putative blockade of, the receptor Ptc. As shownopmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Inc. 769
Figure 5. The ShhNp N Terminus Blocks 5E1 Binding to the Adjacent
Molecule in the Cluster
(A) Intermolecular interactions observed in the human Shh crystal structure (c0
and d0 as shown in Figure 3A) suggest impaired Shh binding to its receptor Ptc
(Ptc contact sites are shown in magenta; Fuse et al. [1999]) or by cocrystalli-
zation and proton resonance (residues H140, 182, 133, 134, and 180 in red;
Bosanac et al. [2009]).
(B) Intermolecular interactions between ShhN monomers potentially block
binding of the conformation-dependent, monoclonal a-Shh antibody 5E1. 5E1
binding to ShhN depends on residues T125, D147, R153, S177, A179, and
H180 (shown in red) and involves residues K87, H133, H134, R155, E176, and
K178 (orange) (Maun et al., 2010).
(C) Impaired 5E1 binding to ShhNpC25S confirms blockade of the zinc coor-
dination site. ShhNp, ShhNpC25S, and C-terminally hexahistidine-tagged
ShhN6xh were 5E1 immunoprecipitated or concentrated by heparin Sepharose
pull-down. ShhNp and ShhN protein signals upon 5E1 immunoprecipitation
were comparable to or exceeded those derived by heparin Sepharose pull-
down; however, 5E1 immunoprecipitation of ShhNpC25S failed to produce
comparable signals. Insets show ShhNp and ShhNpC25S signals at higher
contrast. Note that ShhNpC25S shows slightly increased molecular mass upon
comparison to ShhNp. Bottom: Shh construct employed. A 28 kDa hex-
ahistidine-tagged ShhN6xh was expressed to distinguish the monomeric
protein from processed multimeric ShhNp. (P?) represents that ShhN, if
secreted from Bosc23 cells, may possibly be palmitoylated (Chen et al., 2004).
(D) Constitutively truncated ShhNp5xA was subjected to 5E1 immunoprecipi-
tation and heparin Sepharose pull-down. ShhNp5xA was efficiently 5E1
immunoprecipitated if compared to unprocessed ShhNpC25S in three inde-
pendent assays.
(E) N-terminal processing during release was confirmed by increased 5E1
binding of soluble ShhNp multimers (medium) if compared to the cell surface-
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770 Developmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Iin Figure 5F, equimolar amounts of ShhNpC25S failed to reduce
ShhNp-inducedC3H10T1/2 differentiation, consistent with inter-
molecular interactions shown in Figure 5A and lack of 5E1 anti-
body binding to the unprocessed form.
N-Terminal Truncation of Palmitoylation-Deficient
ShhNpC25S Restores 5E1 Binding and Biological Activity
These results would predict that artificial truncation of
ShhNpC25S, by removal of the inhibitory N-terminal peptide,
would restore 5E1 binding and biological activity of the multi-
meric, nonpalmitoylated protein. Expression of various
ShhNpC25S compound mutants that additionally lacked consec-
utive N-terminal peptides (Figure 6A) did not affect their stable
association (Figure 6B). When proteins contained in equal
amounts of supernatant were either pulled down using heparin
Sepharose beads, or immunoprecipitated using ProteinA-
coupled 5E1, we found comparable relative amounts of material
that bound to heparin (Figure 6C, top), but, as shown before,
inefficient ShhNpC25S 5E1 immunoprecipitation (Figure 6C,
bottom). Notably, consecutive protein truncation restored 5E1
reactivity, the shortest form ShhNpC25S;D26-34 showing strongest
5E1 binding. Consistent with this result, protein truncation also
restored ShhNpC25S biological activity. As shown in Figure 6D,
ShhNpC25S;D26-32 showed comparable activity to wild-type
protein in Hh-dependent chick chondrocyte differentiation (Dre-
ier et al., 2008), as demonstrated by induction of collagenX
expression in five independent experiments (validation of this
assay is shown in Figure S5). ShhNpC25S;D26-34 activity was vari-
able but detected in the experiment shown. We conclude that
the monoclonal antibody 5E1, the receptor Ptc, and the
N-terminal Shh peptide all target an overlapping surface area,
and that N-terminal processing is required for biological activa-
tion of the solubilized protein cluster. Blockade of the Ptc-
binding site by the N-terminal peptide in trans is supported by
full biological activities of monomeric ShhNC25S as well as all cor-
responding mutant proteins in the same assay (Figure 6E). The
observed preference for ShhNp truncation at position 32 may
be explained by the extra amino acid present in the chick
N-terminal Ihh peptide if compared to human or mouse Shh.
IhhNp cleavage at residue G31 results in the N-terminal
sequence S-R-R-R-P-P (CW motif underlined). This closely
matches the ShhNpC25S;D26-32 sequence (S-K-R-R-H-P), indi-
cating that chick chondrocytes may prefer specific processing
at position 31.
Taken together, we suggest a model of coupled ShhNp
release and activation (Figure 7). First, on the cell surface, ShhNp
N-terminal peptides facilitate oligomerization, resulting in stable
association and blockade of zinc coordination sites in trans.
Whereas C-terminal cholesterol mediates ShhNp multimeriza-
tion (Figures 2B, 3D, and 6B), palmitoylation tethers the proteintethered, full-length form (cell). The 5E1 immunoprecipitation of ShhNpC25S
failed to produce signals for the cell-tethered and soluble forms.
(F) ShhNpC25S does not significantly affect ShhNp-induced C3H10T1/2
differentiation (100% versus 105.5% ± 2.7%; n = 3; p = 0.118), supporting the
idea that Ptc binding of the mutant protein is blocked (100% ShhNp versus
17.6%±1.8%ShhNpC25S; n = 3; p = 0.0001). One representative result of three
independent experiments is shown. Error estimates are standard deviations of
the mean. See also Figure S4.
nc.
Figure 6. N-Terminal Truncation of Palmitoylation-Deficient ShhNpC25S Restores 5E1 Binding and Biological Activity
(A) All mutant proteins used lacked the N-terminal cysteine, preventing palmitoylation, in addition to consecutive N-terminal peptides. Red, Hhat substrate
recognition motif; blue, CW motif. Comparable amounts of mutated proteins were employed in all following tests, as determined by immunoblotting.
(B) Comparable amounts of ‘‘large’’ (600 kDa) and ‘‘smaller’’ (around 100 kDa) multimers were detected by gel filtration of ShhNpC25S and compound mutant
proteins additionally lacking N-terminal amino acids 26–31 (ShhNpC25S;D26-31) to 26–34 (ShhNpC25S;D26-34). Elution profiles are expressed relative to the highest
amount of each protein detected in a given fraction set to 100%.
(C) Single and compound mutant proteins were expressed, and the same supernatant was subjected to 5E1 immunoprecipitation or heparin Sepharose pull-
down as shown before. Consecutive N-terminal truncation resulted in increased 5E1 binding; the shortest construct (ShhNpC25S;D26-34) showed the strongest 5E1
reactivity.
(D) ShhNpC25S;D26-32 biological activity was almost fully restored in a chick chondrocyte differentiation assay (Dreier et al., 2008), as indicated by collagenX (a1(X))
expression. ShhNpC25S;D26-34 biological activity was also restored to a limited extent. One representative result of five independent experiments is shown.
(E) Monomeric ShhNC25S and all truncated double-mutant forms induce chick chondrocyte differentiation, indicating that the unprocessed N-terminal peptides
inhibit ShhNpC25S biological activity in trans in this assay. See also Figure S5.
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imal processing. Subsequent N- and C-terminal shedding
results in coupled ShhNp mobilization and activation. Notably,
this model predicts that the role of N-palmitoylation is indirect:
any lack of palmitoylation (by cysteine mutagenesis or acyltrans-Develferase deficiency) (Buglino and Resh, 2008) prevents N-terminal
processing, resulting in solubilized protein clusters with their zinc
coordination sites still occupied by the N termini of associated
molecules. This prevents Ptc binding and results in inactive
proteins.Figure 7. ShhNp Shedding Is Coupled to Its
Activation
Simplified model representing membrane-bound and
soluble forms of ShhNp. We suggest that lipidated ShhNp
may multimerize on producing cells, forming a biologically
inactive pool with its zinc coordination sites (mostly)
blocked (red circle). Shedding results in the loss of inhib-
itory N-terminal peptides and activation of the Ptc
receptor-binding site (green circle) upon release (top). We
suggest that lack of ShhNpC25S N-palmitoylation may
prevent membrane-proximal positioning of the sheddase
cleavage site, resulting in C-terminally processed clusters
with their Ptc receptor-binding sites still blocked by
unprocessedN termini of adjacentmolecules in the cluster
(bottom).
opmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Inc. 771
Developmental Cell
Shedding-Mediated Sonic Hedgehog ActivationDISCUSSION
The lysostaphin-type enzymes, D-Ala-D-Ala aminopeptidase
and carboxypeptidase, and Shh N-terminal domain are collec-
tively known as LAS enzymes (Bochtler et al., 2004; Firczuk
et al., 2005). Lysostaphin-type enzymes are produced as full-
length, unprocessed forms and require proteolytic processing
for activation. Consistent with this, structural analysis of the
LAS member LytM, an autolysin from Staphylococcus aureus,
shows a zinc coordination site located at the bottom of a narrow
groove of the secreted proenzyme that is partially filled by
a glycine-rich loop of a neighboring molecule in the crystal (Firc-
zuk et al., 2005). This arrangement is strikingly similar to the
crystal packing of related human ShhN shown in this work.
ShhNp proprotein processing is special, however, in that the
N terminus is palmitoylated, resulting in strict coupling of
N-terminal ShhNp processing by extracellular proteases, such
as one or more ADAMs, and subsequent ShhNp release from
the cell with ShhNp activation. We thus suggest that only
N-terminally truncated ShhNp is biologically active, binds to its
receptor Ptc, and is bound by the conformational a-Shh antibody
5E1. The following data are consistent with this conclusion: (1)
membrane-extracted ShhNp fails to bind to 5E1, whereas
secreted Shh forms bind to 5E1 (Feng et al., 2004); (2) HhNpC85S
is not internalized by its receptor Ptc in Drosophila imaginal disc
epithelia (Callejo et al., 2006); and (3) Hhip/Shh interactions that
compete with Ptc binding to the zinc coordination site of Hhs
seem analogous to Timp1-MMP3 inhibitor-enzyme interactions
(Gomis-Ru¨th et al., 1997). In both systems, the Zn2+ coordination
sphere is completed upon complex formation (Bosanac et al.,
2009). Such an interaction, however, would be blocked by the
unprocessed N-terminal peptide.
Our studies further demonstrate that the C-terminal choles-
terol modification is sufficient for cell-surface clustering (Feng
et al., 2004; Gallet et al., 2006). We also found that cell surface
HSPGs assist ShhNp multimerization, consistent with the loss
of visible Hh-mCFP clusters upon a combined HSPG knock-
down in the fly (Vyas et al., 2008). Moreover, palmitoylation
ensures N-terminal processing of ShhNp. Notably, the essential
role of N-terminal processing for ShhNp activation may explain
the unusual attachment of palmitate via an amide bond to the
a-amino group of Shh/Hh. Thioester-linked palmitate can be
removed by intracellular and extracellular palmitoyl-protein thio-
esterases, allowing S-palmitoylated proteins to undergo deacy-
lation/reacylation reactions (Resh, 2006). In Hhs, however, this
would result in a situation comparable to that in palmitoyl acyl-
transferase-deficient mutants, which show strongly impaired
Shh signaling. In contrast, amide-linked palmitate does not
undergo deacylation, resulting in stable attachment of the fatty
acid to Shh. This restricts possible modes of ShhNp release to
cell-surface shedding that rules out the solubilization of any
unprocessed, inactive protein clusters.
Several lines of evidence indicate that subsequent Hh long-
range signaling in vivo may require direct cell-cell contact.
According to this scheme, HhNp/ShhNp is displaced from the
cell surface upon binding to Disp (Ma et al., 2002) and Disp inter-
action with anHSPGon adjacent receiving cells. The proteinmay
then remain HSPG associated, allowing it to pass to more
distantly located cells (Gallet et al., 2006), or it may interact772 Developmental Cell 20, 764–774, June 14, 2011 ª2011 Elsevier Iwith Ptc, resulting in its internalization. We suggest that ShhNp
processing contributes to Disp-mediated protein release in this
model. The requirement for direct cell-to-cell contacts may be
explained by the essential role of continuous HSPG expression
for protein transport in the gradient-forming field (Bellaiche
et al., 1998; Desbordes and Sanson, 2003; Han et al., 2004).
HSPGs may localize the Hh proteins to the cell surface via
restricted diffusion, or stabilize the processed soluble clusters.
Such HSPG functions would add to the established types of
modes by which the ShhNp signal is transmitted to receiving
cells in different physical contexts.
EXPERIMENTAL PROCEDURES
Cloning and Expression of Recombinant Proteins
Shh constructs were generated frommurine cDNA (NM_009170) using primers
carrying desired point mutations or deletions by PCR. PCR products (nucleo-
tides 1–1314, corresponding to amino acids 1–438) were ligated into pGEM
(Promega), sequenced, and ligated into pcDNA3.1 (Invitrogen) for the Disp-
dependent expression of multimeric, lipidated 19 kDa ShhNp in Bosc23 cells
(Figure S1) (Burke et al., 1999). We confirmed expression of Disp, ADAM10,
ADAM12, ADAM17, and glypican family members 1–6, all of which were impli-
cated in ShhNp release, in Bosc23 cells by semiquantitative RT-PCR. Where
indicated, a HA tag was inserted between N-terminal amino acids G32 and
K33 by site-directed mutagenesis (Stratagene), resulting in internally HA-
tagged ShhNpHA. PCR products (nucleotides 1–594, corresponding to amino
acid 1–198 of murine Shh) were also cloned into pGEX for E. coli expression of
unlipidated 19 kDa ShhN. Truncated Shh cDNA was also ligated into
pcDNA3.1/myc-HisC (Invitrogen) for the expression of secreted, C-terminally
hexahistidine-tagged 28 kDa ShhN6xh (the large size due to the presence of
the cloning site) in Bosc23 cells. To generate soluble alkaline phosphatase
sAPShhN fusion proteins, the N-terminal sequence of Shh (amino acids
25–198) was produced by PCR, sequence verified, and ligated into gWIZ
(Gene Therapy Systems, San Diego, CA, USA). Site-directed mutagenesis of
C25, the dimer contact site (amino acids E72, R73, and K75), and the
heparin-binding CW motif (amino acids 33–39) was also conducted (Strata-
gene). ADAM constructs lacking the cytoplasmic tail were generated from
cDNA (ADAM10: NM_007399, ADAM12: BC_060804, ADAM17: NM_009615,
all from ImaGenes, Berlin, Germany) by PCR. PCR products were sequenced
and subsequently cloned into pcDNA3.1 for the expression in Bosc23 cells.
Dominant-negative mutant (Ma et al., 2002) and wild-type Disp were gener-
ated from Disp cDNA (NM_026866, ImaGenes). Hhat (NM_018194, ImaGenes)
acyltransferase gene silencing was achieved by transfection of 400 ng (40
pmol) Mission esiRNA per 5 3 105 Bosc23 cells using HiPerFect (QIAGEN).
Disp gene silencing was achieved by transfection of 600 ng Sigma
SASI_Hs02-00360509/SASI_Hs02-00360509_AS RNA duplex per 5 3 105
Bosc23 cells using HiPerFect. Nonsilencing Sigma SIC001 RNA was used
as a control. Transfection of Shh constructs was conducted the following
day using standard protocols, and protein analysis was performed 28–48 hr
posttransfection. Polyclonal anti-Disp antibodies (SAB2103733, Sigma,
1:1000 in 5% milk powder) were preadsorbed on western blots of Bosc23
cell lysate run on 15% SDS-PA gels (proteins >100 kDa were not transferred),
and subsequently added to western blots of 10% SDS-PA-gel separated
Bosc23 lysate to confirm efficient protein knockdown.
Cell Culture and Protein Analysis
Human Bosc23 cells were cultured in DMEM (GIBCO BRL) with 10% fetal calf
serum (FCS) and 100 mg/ml penicillin/streptomycin andwere transfected using
PolyFect (QIAGEN). Cells were grown for 36–48 hr and proteins secreted into
serum-containing or serum-freemedia overnight. Where indicated, ShhNp-ex-
pressing Bosc23 cells were incubated for 2 hr in the presence of MbCD. Media
were ultracentrifuged at 210,000 3 g for 60 min to remove proteins bound to
membranous remnants, proteins TCA precipitated or pulled down using
40 ml heparin Sepharose beads (Sigma) per 1 ml medium, and proteins
analyzed by SDS-PAGE, followed by western blotting. Immunodetection
was conducted using polyclonal a-ShhN (goat IgG; R&D Systems) ornc.
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primary protein detection. The HA tag was detected using a-HA antibodies
(clone HA7; Sigma). Visualization was performed after incubation with perox-
idase-conjugated IgG (Dianova) followed by chemiluminescent detection
(Pierce). For radiolabeling, 1 mCi [9,19(n)-3H] palmitic acid was added to
Shh-transfected Bosc23 cells cultured in 35 mm dishes for 28 hr under
serum-free conditions prior to ShhNp release over night. 3H palmitic acid-
labeled cells as well as the harvestedmedia were subjected to heparin Sephar-
ose pull-down to increase the signal-to-noise ratio. After SDS-PAGE, gels
were immunoblotted, and the same blot was analyzed by autoradiography.
Chromatography
Proteins were purified by FPLC (A¨kta Protein Purifier; Pharmacia) at 4C. Gel
filtration analysis was performed by using a Superdex 200 10/300 GL column
(Pharmacia) equilibrated with PBS at 4C. Eluted fractions were TCA precipi-
tated, resolved by 15% SDS-PAGE, and immunoblotted. Signals were quan-
tified using ImageJ. For pull-down experiments, 40 ml heparin Sepharose
beads was added to 500 ml Shh-containing media and incubated overnight
on a rotator. 5E1 immunoprecipitation employing 10mg 5E1 (DSHB, University
of Iowa, IA, USA) coupled to 2.5 mg ProteinA Sepharose beads (Sigma) per IP
(500 ml–1 ml medium) was conducted simultaneously.
Shh Reporter Assays
Assays for Hh pathway activation in Shh-LIGHT2 cells, a clonal NIH 3T3 cell
line stably incorporating Gli-dependent firefly luciferase and constitutive
Renilla luciferase reporters, were conducted as described (Taipale et al.,
2000). C3H10T1/2 cells (Nakamura et al., 1997) were grown in DMEM supple-
mented with 10% FCS and antibiotics. Posttransfection, Bosc23 cells were
cultured in DMEM/10%FCS for at least 30 hr. Conditioned media were then
sterile filtered, mixed 1:1 with DMEM containing 10%FCS and antibiotics,
and applied to C3H10T1/2 cells in 15 mm plates. Generally, due to variable
expression levels, mutant and wild-type proteins required adjustment to
comparable levels before induction of C3H10T1/2 differentiation. For adjust-
ment, proteins were detected by immunoblotting, and quantification of de-
tected bands was conducted with ImageJ. To control samples, 2.5 mM CA
was added. Cells were lysed 5 days after induction (20 mM HEPES, 150 mM
NaCl, 0.5% Triton X-100 [pH 7.4]), and osteoblast-specific AP activity was
measured at 405 nm after addition of 120 mM p-Nitrophenyl phosphate
(Sigma) in 0.1 M glycine buffer (pH 10.4). Assays were performed in triplicate.
Statistical Analysis
All statistical analysis was performed in Prism using Student’s t test (two-
tailed, unpaired, CI 95%). All error estimates are standard deviations of the
mean.
Chondrocyte Differentiation
Chondrocytes were isolated from the cranial third of 17-day-old chick embryo
sterna by overnight digestion with collagenase and cultured in agarose
suspension cultures under serum-free conditions. Briefly, cells were sus-
pended in 0.5% low-melting agarose in DMEM and allowed to sediment on
the culture dishes precoated with 1% high-melting agarose in water. Cells
were grown at densities of 2 3 106 cells/ml in DMEM mixed 1:1 with condi-
tioned, serum-free medium from Shh-expressing cells, containing 60 mg/ml
b-aminopropionitrile fumarate, 25 mg/ml sodium ascorbate, 1 mM cysteine,
1 mM pyruvate, 100 U/ml penicillin, and 100 mg/ml streptomycin. After
14 days in culture, newly synthesized chondrocyte proteins weremetabolically
labeled for 24 hr with 1 mCi/ml of 14Cproline (250 Ci/mmol; NEN Life Science
products). Collagens were isolated after limited digestion with pepsin and
were analyzed by SDS-PAGE, followed by fluorography (Dreier et al., 2008).
Alternatively, collagenX was detected on immunoblots using anti-chicken
collagenX IgG (X-AC9, DSHB, University of Iowa, USA).
Molecular Modeling
The crystal structure of human Shh (PDB: 3M1N) (Pepinsky et al., 2000) was
displayed employing the PyMOL Molecular Graphics System, Version 1.3,
Schro¨dinger, LLC. PyMOL was further used to generate a set of protein coor-
dinates related by crystal symmetry, and the sizes of surfaces buried in
protein-protein interfaces were calculated for all different pairs of protein coor-Develdinates by MSMS (Sanner et al., 1996). Pairs with buried surfaces exceeding
500 A˚2 were inspected visually using PyMOL.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
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